Please find attached outcome of Board meeting of SBI Life Insurance Company Limited held on July 24, 2026

July 24, 2026 SBIL/CS/NSE-BSE/2627/69 Vice President General Manager Listing Department, Listing Department, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block, BKC, Dalal Street, Bandra (East), Mumbai 400051 Mumbai 400001 NSE Symbol: SBILIFE BSE Scrip Code: 540719 Dear Sir / Madam, Subject: Outcome of Board Meeting – Financial Results In continuation to our intimation vide ref. no. SBIL/CS/NSE-BSE/2627/56 dated July 10, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that the meeting of the Board of Directors of the Company commenced at 11:00 A.M. and concluded at 02:35 P.M. on Friday, July 24, 2026 which inter-alia approved the Unaudited Financial Results for the quarter ended June 30, 2026. The above information is also made available on the Company’s website at www.sbilife.co.in. Pursuant to Regulation 33 of the Listing Regulations and other applicable requirements, a copy of the Unaudited Financial Results for the quarter ended June 30, 2026 together with the Limited Review Reports in the prescribed format is enclosed. We would like to state that M/s. K S Aiyar & Co., Chartered Accountants and M/s. J Singh & Associates, Chartered Accountants, joint statutory auditors of the Company, have issued Limited Review Reports with unmodified opinion. Further, the trading window to deal in securities of the Company will be re-opened from Monday, July 27, 2026, for all the Designated Persons of the Company. We request you to kindly take the above information on record. Thanking You, Yours faithfully, Girish Manik Company Secretary ACS No. 26391 Encl: A/a Public SBI Life Insurance Company Ltd. Registered and Corporate Office: Natraj, M.V. Road and Western Express Highway Junction Andheri (East), Mumbai 400 069. Tel.: (022) 6191 0000/ 3968 0000 IRDAI Regn. No. 111. CIN: L99999MH2000PLC129113 www.sbilife.co.in SEARCHABLE FORMAT SBI Life Insurance Company Limited Statement of Unaudited Financial Results for the quarter ended June 30, 2026 ( in Lakhs) SI. Particulars Three months ended/ As at Year ended/ As No. June 30, March 31, June 30, March 31, 2026 2026 2025 2026 (Unaudited) (Audited) (Audited) (Audited) POLICYHOLDERS' A/C 1 Gross premium income (a) First Year Premium 4,95,493 5,09,271 3,53,947 21,84,099 (b) Renewal Premium 12,38,179 16,71,396 10,54,628 58,73,477 (c) Single Premium 3,95,293 6,13,218 3,72,814 20,71,034 2 Net premium income1 20,07,821 27,68,379 17,17,850 99,95,592 3 Income from investments (Net)2 25,97,702 (23,93,872) 21,52,514 11,06,211 4 Other income 3,547 3,875 (773) 7,392 5 Transfer of funds from Shareholders' A/c - 1,87,393 - 1,87,393 6 Total (2 to 5) 46,09,070 5,65,775 38,69,591 1,12,96,588 7 Commission on (a) First Year Premium 61,236 41,616 50,549 2,80,276 (b) Renewal Premium 25,151 44,033 22,387 1,45,226 (c) Single Premium 6,569 262 5,669 24,069 8 Net Commission1 92,956 85,911 78,605 4,49,571 9 Operating Expenses related to insurance business (a + b): 1,63,546 1,66,825 1,12,912 6,22,546 (a) Employees remuneration and welfare expenses 79,863 70,690 70,916 3,25,175 (b) Other operating expenses 83,683 96,135 41,996 2,97,371 10 Expenses of Management (8+9) 2,56,502 2,52,736 1,91,517 10,72,117 11 Provisions for doubtful debts (including bad debts written off) 10 31 29 104 12 Provisions for diminution in value of investments and provision for (26) (2,106) (1,235) 790 standard assets & non standard assets 13 Goods and Service Tax (GST) on charges 40 (12) 26,109 52,530 14 Provision for taxes 4,725 5,121 4,525 15,945 15 Benefits Paid3 (Net)1 13,12,672 16,25,462 10,11,837 54,32,349 16 Change in actuarial liability 29,81,156 (15,34,836) 25,89,994 43,93,816 17 Total (10+11+12+13+14+15+16) 45,55,079 3,46,395 38,22,776 1,09,67,651 18 Surplus/(Deficit) (6-17) 53,991 2,19,380 46,815 3,28,937 19 Appropriations (a) Transferred to Shareholders A/c 45,778 2,36,362 32,155 3,16,009 (b) Funds for Future Appropriations 8,213 (16,982) 14,660 12,928 20 Details of Surplus/ (Deficit) (a) Interim & terminal bonus paid 13,433 26,736 8,986 70,333 (b) Allocation of bonus to policyholders - 2,06,055 - 2,06,055 (c) Surplus shown in the Revenue Account 53,991 2,19,380 46,815 3,28,937 Total Surplus 67,424 4,52,171 55,801 6,05,325 SHAREHOLDERS' A/C 21 Transfer from Policyholders' Account 45,778 2,36,362 32,155 3,16,009 22 Total income under Shareholders ' Account (a) Investment Income2 28,155 32,596 29,286 1,29,743 (b) Other income 19 - - - 23 Expenses other than those related to insurance business 694 270 755 2,974 24 Transfer of funds to Policyholders' A/c - 1,87,393 - 1,87,393 25 Provisions for doubtful debts (including write off) - - - - Provisions for diminution in value of investments and provision for (1,329) (283) (409) 1,645 26 standard assets & non standard assets 27 Profit/ (loss) before tax 74,587 81,578 61,095 2,53,740 28 Provisions for tax 2,094 1,114 1 ,658 6 ,710 29 Profit/ (loss) after tax and before Extraordinary Items 72,493 80,464 59,437 2,47,030 30 Extraordinary Items (Net of tax expenses) - - - - 31 Profit/ (loss) after tax and Extraordinary Items 72,493 80,464 59,437 2,47,030 32 Dividend per share ( ): (a) Interim Dividend - 2.70 - 2 .70 (b) Final Dividend - - - - 33 Profit/(Loss) carried to Balance Sheet4 18,55,499 17,83,006 16,22,494 17,83,006 34 Paid up equity share capital 1,00,324 1,00,309 1,00,235 1,00,309 35 Reserve & Surplus (excluding Revaluation Reserve) 18,82,201 18,08,305 16,40,502 18,08,305 36 Fair Value Change Account and Revaluation Reserve (Shareholders) 29,401 (75) 43,079 ( 75) 37 Total Assets: (a) Investments: Shareholders ' 18,47,759 16,71,008 16,39,406 16,71,008 Policyholders Fund excluding Linked Assets 2,22,19,738 2,10,71,296 1,91,91,706 2,10,71,296 Assets held to cover Linked Liabilities 2,83,47,942 2,58,94,445 2,66,79,423 2,58,94,445 (b) Other Assets (Net of current liabilities and provisions) 1,89,169 5,68,587 3,07,615 5,68,587 1 Net of reinsurance 2 Net of amortisation and losses (including capital gains) 3 Inclusive of interim bonus & terminal bonus 4 Represents accumulated profit SI. Particulars Three months ended/ As at Year ended/ As No. June 30, March 31, June 30, March 31, 2026 2026 2025 2026 (Unaudited) (Audited) (Audited) (Audited) 38Analytical Ratios1 : (i) Solvency Ratio 1 .96 1.90 1 .96 1 .90 (ii) Expenses Management Ratio 12.05% 9.05% 10.75% 10.59% (iii) Policyholder's liabilities to shareholders' fund 2514.41% 2478.09% 2580.64% 2478.09% (iv) Earnings per share ( ): a)BasicEPSbeforeandafterextraordinaryitems(netoftax 7.23 8.02 5.93 2 4.64 expense) for the period2 b)DilutedEPSbeforeandafterextraordinaryitems(netoftax expense) for the period2 7.22 8.02 5.93 2 4.62 (v) NPA ratios: (for policyholders' fund) a) Gross NPAs - Non Linked Par - - - - Non Par - - - - - Linked Non Par - - - - Net NPAs - Non Linked Par - - - - Non Par - - - - - Linked Non Par - - - - b) % of Gross NPAs - Non Linked Par - - - - Non Par - - - - - Linked Non Par - - - - % of Net NPAs - Non Linked Par - - - - Non Par - - - - - Linked Non Par - - - - (vi) Yield on Investments (on policyholders' fund) A. Without unrealised gains Non Linked Par 7.19% 7.36% 8.64% 8.34% Non Par 7.20% 7.29% 7.49% 7.41% Sub -Total : Non-Linked 7.19% 7.30% 7.85% 7.69% Linked Par NA NA NA NA Non Par 5.48% 5.54% 9.53% 7.35% Sub - Total : Linked 5.48% 5.54% 9.53% 7.35% Grand Total 6.29% 6.37% 8.73% 7.51% B. With unrealised gains Non Linked Par 23.35% -17.91% 11.03% 0.22% Non Par 21.16% -11.23% 6.69% 0.23% Sub - Total : Non-Linked 21.82% -13.35% 8.10% 0.23% Linked Par NA NA NA NA Non Par 34.07% -43.57% 29.25% -1.39% Sub - Total : Linked 34.07% -43.57% 29.25% -1.39% Grand Total 28.60% -30.20% 19.92% -0.67% (vii) NPA ratios: (for shareholders' fund) a) Gross NPAs - - - - Net NPAs - - - - b) % of Gross NPAs - - - - % of Net NPAs - - - - (viii) Yield on Investments (on shareholders' fund) [Showing first 8,000 characters — download PDF for full document]